Related references
Note: Only part of the references are listed.Interaction of membrane/lipid rafts with the cytoskeleton: Impact on signaling and function Membrane/lipid rafts, mediators of cytoskeletal arrangement and cell signaling
Brian P. Head et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2014)
Dyslipidemia and the Risk of Alzheimer's Disease
Christiane Reitz
CURRENT ATHEROSCLEROSIS REPORTS (2013)
Role of Cholesterol in APP Metabolism and Its Significance in Alzheimer's Disease Pathogenesis
M. Maulik et al.
MOLECULAR NEUROBIOLOGY (2013)
Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease
Jiaqi Yao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Negative cooperativity in binding of muscarinic receptor agonists and GDP as a measure of agonist efficacy
J. Jakubik et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Subtype Differences in Pre-Coupling of Muscarinic Acetylcholine Receptors
Jan Jakubik et al.
PLOS ONE (2011)
Structural basis of G protein-coupled receptor-G protein interactions
Jianxin Hu et al.
NATURE CHEMICAL BIOLOGY (2010)
Cholesterol in Alzheimer's Disease: Unresolved Questions
Massimo Stefani et al.
CURRENT ALZHEIMER RESEARCH (2009)
Membrane cholesterol content influences binding properties of muscarinic M2 receptors and differentially impacts activation of second messenger pathways
Pavel Michal et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Impairment of muscarinic transmission in transgenic APPswe/PS1dE9 mice
E. Machová et al.
NEUROBIOLOGY OF AGING (2008)
Muscarinic M2 receptors directly activate Gq/11 and Gs G-proteins
P. Michal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Differences in kinetics of xanomeline binding and selectivity of activation of G proteins at M1 and M2 muscarinic acetylcholine receptors
Jan Jakubik et al.
MOLECULAR PHARMACOLOGY (2006)
Regulation of cholesterol and sphingomyelin metabolism by amyloid-β and presenilin
MOW Grimm et al.
NATURE CELL BIOLOGY (2005)
Neuronal membrane cholesterol loss enhances amyloid pepticle generation
J Abad-Rodriguez et al.
JOURNAL OF CELL BIOLOGY (2004)
The G-protein-coupled receptors in the human genome form five main families.: Phylogenetic analysis, paralogon groups, and fingerprints
R Fredriksson et al.
MOLECULAR PHARMACOLOGY (2003)
Structure and activation of muscarinic acetylcholine receptors
EC Hulme et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2003)
Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts
R Ehehalt et al.
JOURNAL OF CELL BIOLOGY (2003)
Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains
MD Ledesma et al.
EMBO REPORTS (2003)
Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo
K Fassbender et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Dual effects of muscarinic M2 acetylcholine receptors on the synthesis of cyclic AMP in CHO cells:: dependence on time, receptor density and receptor agonists
P Michal et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Initial sequencing and analysis of the human genome
ES Lander et al.
NATURE (2001)
Share Paper
